In this study, the expression levels of TPD52 and miR-133a in tissue samples of patients with pancreatic cancer were detected to investigate the value of TPD 52 and Mir-133a in evaluating the prognosis of pancreatic cancer surgery. The gene discussed is TPD52; the disease is familial pancreatic carcinoma.